A detailed history of Dafna Capital Management LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 935,894 shares of AXGN stock, worth $13.9 Million. This represents 3.37% of its overall portfolio holdings.

Number of Shares
935,894
Previous 935,894 -0.0%
Holding current value
$13.9 Million
Previous $6.78 Million 93.67%
% of portfolio
3.37%
Previous 1.74%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.68 - $9.26 $2.83 Million - $5.59 Million
603,791 Added 181.81%
935,894 $4.68 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $2.92 Million - $5.31 Million
332,103 New
332,103 $3.11 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $627M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.